Breast cancer screening helps identify possible signs of breast cancer before symptoms become noticeable. Early detection can improve the chances of successful treatment and help healthcare professionals identify appropriate care options. Common screening methods include mammography, clinical breast examinations, and, in selected circumstances, magnetic resonance imaging.
Breast cancer develops when cells in breast tissue grow abnormally and form a tumor. Screening is intended to detect potential cancer in people who do not have noticeable symptoms. It differs from diagnostic testing, which investigates symptoms such as a lump, nipple discharge, or changes in breast appearance. Screening recommendations vary among medical organizations and countries, so individual decisions should consider current guidance and personal risk factors. Although screening cannot prevent every case of breast cancer, it can help identify some cancers at an earlier stage.
Several screening methods are available, but mammography is the primary screening test for most women at average risk. Mammograms use low-dose X-rays to identify changes in breast tissue that may require further evaluation. Other examinations may be appropriate depending on symptoms, age, breast density, and the likelihood of developing breast cancer.
Common screening methods include:
Mammography: Uses low-dose X-rays to detect abnormalities, including small tumors and certain calcium deposits that may not be noticeable during a physical examination.
Digital breast tomosynthesis: Also called three-dimensional mammography, this technique captures images from different angles to create detailed views of breast tissue.
Clinical breast examination: A healthcare professional examines the breasts and surrounding areas for lumps or other unusual changes. This examination does not replace recommended mammography.
Breast MRI: Uses magnetic fields to create detailed images. It may be recommended alongside mammography for certain people at high risk of breast cancer.
Diagnostic breast imaging: Additional mammography, ultrasound, or other tests may be used to investigate an abnormal screening result or a breast symptom.
Each method has benefits and limitations. Screening may produce false-positive results that require additional testing, while some cancers may not be detected. People should discuss suitable screening intervals and examination options with a qualified healthcare professional.
Early detection involves identifying breast cancer before it progresses to a more advanced stage. Screening decisions are influenced by age, family history, inherited genetic changes, previous breast conditions, and other individual factors. People with a strong family history or certain inherited gene variants may need an earlier or more intensive screening plan.
Important considerations for early detection include:
Age and screening frequency: Recommendations differ by age and medical organization. For example, the US Preventive Services Task Force recommends mammography every two years for women aged 40 to 74 at average risk.
Family and genetic history: A history of breast or ovarian cancer in close relatives, or certain inherited genetic variants, may increase risk.
Breast changes: A new lump, nipple inversion, unusual discharge, skin dimpling, or persistent changes in breast shape should be evaluated promptly rather than waiting for a routine screening appointment.
Follow-up testing: An abnormal mammogram does not automatically mean cancer is present. Additional imaging or a biopsy may be needed to establish a diagnosis.
Personalized medical advice: People with previous breast cancer, high-risk breast lesions, or other significant risk factors may require a different screening schedule.
Breast awareness is useful because it helps people recognize changes that are unusual for them. However, self-examination alone is not a substitute for recommended screening or medical assessment.
Understanding breast cancer screening methods supports informed conversations with healthcare professionals. The appropriate approach depends on individual risk, age, available services, and current medical guidance. Screening has potential benefits as well as limitations, making personalized decisions important. Anyone who notices a new or persistent breast change should seek medical evaluation, regardless of when their last screening test occurred.